The recent ASX Small and Mid-Cap Conference was attended by more than 2000 investors, Analysts and Financial Advisors. Star Combo Pharma was thrilled to participate in the On Demand segment of the conference, with CEO Su Zhang providing investors with provide an overview of the company, as well as an update on the company’s ongoing strategic direction.
To access the recording of the presentation, please click here.